R-spondin signalling is essential for the maintenance and differentiation of mouse nephron progenitors.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 23 11 2019
accepted: 23 04 2020
pubmed: 24 4 2020
medline: 31 3 2021
entrez: 24 4 2020
Statut: epublish

Résumé

During kidney development, WNT/β-catenin signalling has to be tightly controlled to ensure proliferation and differentiation of nephron progenitor cells. Here, we show in mice that the signalling molecules RSPO1 and RSPO3 act in a functionally redundant manner to permit WNT/β-catenin signalling and their genetic deletion leads to a rapid decline of nephron progenitors. By contrast, tissue specific deletion in cap mesenchymal cells abolishes mesenchyme to epithelial transition (MET) that is linked to a loss of Kidneys filter waste out of the bloodstream to produce urine. Each kidney contains many structures called nephrons which separate the waste from the blood. The number of nephrons in a kidney varies between people, and those with low numbers have a higher risk of chronic kidney disease. Nephrons are formed before birth from a specific group of so-called progenitor cells. Each of these cells can either divide to make others like itself, or it can specialize to make nephron cells. At the end of embryonic kidney development, all the progenitor cells become nephron cells. Cells that specialize to become part of a nephron first go through a change called a mesenchyme-to-epithelial transition. Epithelial cells move less than mesenchymal cells, and also develop a clear structure where the two ends of the cell adapt to different roles. Evidence suggests that a cell communication process called WNT/β-catenin signaling controls this transition. Yet the details of how this transition is controlled are not fully understood. One way to activate WNT/β-catenin signaling is with R-spondin proteins, which have been found in developing kidneys. Vidal et al. studied R-spondins during the embryonic development of kidneys in mice. Removing R-spondins stopped the progenitor cells from producing more of themselves and increased the number that died. The R-spondins were also needed for the progenitor cells to specialize as nephron cells through the mesenchyme-to-epithelial transition. Further results revealed that R-spondins activate WNT/β-catenin signaling in these cells, even though the proteins that usually act as R-spondin receptors (called LGR4/5/6) could be removed without affecting the results. This suggests that R-spondins interact with different receptor proteins during kidney development. These findings highlight the role of R-spondins and WNT/β-catenin signaling in kidney development. Future studies will seek the receptor proteins that R-spondins interact with in kidneys. They may also look to understand how R-spondins balance their different roles in progenitor cells and during cell specialization. These results in mice could also be extended to determine their relevance in human health and disease, including chronic kidney disease, which is responsible for more deaths than breast or prostate cancer.

Autres résumés

Type: plain-language-summary (eng)
Kidneys filter waste out of the bloodstream to produce urine. Each kidney contains many structures called nephrons which separate the waste from the blood. The number of nephrons in a kidney varies between people, and those with low numbers have a higher risk of chronic kidney disease. Nephrons are formed before birth from a specific group of so-called progenitor cells. Each of these cells can either divide to make others like itself, or it can specialize to make nephron cells. At the end of embryonic kidney development, all the progenitor cells become nephron cells. Cells that specialize to become part of a nephron first go through a change called a mesenchyme-to-epithelial transition. Epithelial cells move less than mesenchymal cells, and also develop a clear structure where the two ends of the cell adapt to different roles. Evidence suggests that a cell communication process called WNT/β-catenin signaling controls this transition. Yet the details of how this transition is controlled are not fully understood. One way to activate WNT/β-catenin signaling is with R-spondin proteins, which have been found in developing kidneys. Vidal et al. studied R-spondins during the embryonic development of kidneys in mice. Removing R-spondins stopped the progenitor cells from producing more of themselves and increased the number that died. The R-spondins were also needed for the progenitor cells to specialize as nephron cells through the mesenchyme-to-epithelial transition. Further results revealed that R-spondins activate WNT/β-catenin signaling in these cells, even though the proteins that usually act as R-spondin receptors (called LGR4/5/6) could be removed without affecting the results. This suggests that R-spondins interact with different receptor proteins during kidney development. These findings highlight the role of R-spondins and WNT/β-catenin signaling in kidney development. Future studies will seek the receptor proteins that R-spondins interact with in kidneys. They may also look to understand how R-spondins balance their different roles in progenitor cells and during cell specialization. These results in mice could also be extended to determine their relevance in human health and disease, including chronic kidney disease, which is responsible for more deaths than breast or prostate cancer.

Identifiants

pubmed: 32324134
doi: 10.7554/eLife.53895
pii: 53895
pmc: PMC7228766
doi:
pii:

Substances chimiques

LGR4 protein, mouse 0
Lgr5 protein, mouse 0
Lgr6 protein, mouse 0
R-spondin3 protein, mouse 0
RSPO1 protein, mouse 0
Receptors, G-Protein-Coupled 0
Thrombospondins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Commission
ID : 305608
Organisme : Ligue Contre le Cancer
ID : Equipe labelisee

Informations de copyright

© 2020, Vidal et al.

Déclaration de conflit d'intérêts

VV, FJ, SR, EG, ES, ML, BR, MC, AS No competing interests declared

Références

Curr Top Dev Biol. 2016;117:31-64
pubmed: 26969971
PLoS One. 2014 Mar 03;9(3):e89835
pubmed: 24595031
Dev Cell. 2004 Oct;7(4):525-34
pubmed: 15469841
Nat Commun. 2014 Jul 17;5:4444
pubmed: 25031030
Development. 2019 Jun 12;146(12):
pubmed: 31118232
Elife. 2018 Feb 06;7:
pubmed: 29405118
Dev Biol. 2007 Jan 1;301(1):218-26
pubmed: 16963017
PLoS One. 2019 Apr 12;14(4):e0215139
pubmed: 30978219
Dev Cell. 2015 Oct 12;35(1):49-62
pubmed: 26460946
Semin Cell Dev Biol. 2019 Jul;91:94-103
pubmed: 30030141
Elife. 2019 Jan 24;8:
pubmed: 30676318
Hum Mol Genet. 2008 May 1;17(9):1264-77
pubmed: 18250098
Development. 2001 Apr;128(8):1253-64
pubmed: 11262227
Dev Cell. 2011 Mar 15;20(3):303-14
pubmed: 21397842
Cell Rep. 2017 Aug 22;20(8):1745-1754
pubmed: 28834739
Cell Rep. 2015 Dec 1;13(9):1757-64
pubmed: 26655896
Pediatr Nephrol. 2011 Sep;26(9):1529-33
pubmed: 21604189
Stem Cell Reports. 2014 Oct 14;3(4):650-62
pubmed: 25358792
Dev Cell. 2016 Jan 11;36(1):79-93
pubmed: 26766444
Nature. 1994 Dec 15;372(6507):679-83
pubmed: 7990960
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4640-5
pubmed: 23487745
Development. 2008 Nov;135(22):3655-64
pubmed: 18842812
Blood. 2018 Mar 1;131(9):982-994
pubmed: 29212806
J Am Soc Nephrol. 2007 Apr;18(4):1130-9
pubmed: 17329570
Dev Cell. 2005 Aug;9(2):283-92
pubmed: 16054034
Dev Biol. 2002 Apr 15;244(2):305-18
pubmed: 11944939
Dev Biol. 2018 Aug 1;440(1):13-21
pubmed: 29705331
Nature. 2008 Jul 3;454(7200):109-13
pubmed: 18568026
Dev Biol. 2018 Sep 1;441(1):42-51
pubmed: 29859889
Annu Rev Cell Dev Biol. 2018 Oct 6;34:427-450
pubmed: 30125139
BMJ Open. 2018 Dec 14;8(12):e020759
pubmed: 30552240
Cell Stem Cell. 2008 Aug 7;3(2):169-81
pubmed: 18682239
Nat Genet. 2012 Jul 15;44(8):904-9
pubmed: 22797727
Mol Cell Biol. 2002 Feb;22(4):1184-93
pubmed: 11809809
Nephron Exp Nephrol. 2006;104(2):e63-75
pubmed: 16785743
Dev Dyn. 1998 Dec;213(4):440-51
pubmed: 9853965
Nature. 2018 May;557(7706):564-569
pubmed: 29769720
Dev Biol. 2016 Oct 15;418(2):297-306
pubmed: 27346698
Dev Biol. 2014 Jun 15;390(2):181-90
pubmed: 24680895
Dev Cell. 2015 Jul 27;34(2):229-41
pubmed: 26190145
Development. 2011 Apr;138(7):1247-57
pubmed: 21350016
Dev Cell. 2012 Sep 11;23(3):637-51
pubmed: 22902740
Cell Rep. 2012 Sep 27;2(3):540-52
pubmed: 22999937
Genes Dev. 2014 Feb 15;28(4):305-16
pubmed: 24532711
Development. 2007 Jul;134(13):2533-9
pubmed: 17537789

Auteurs

Valerie Pi Vidal (VP)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Fariba Jian-Motamedi (F)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Samah Rekima (S)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Elodie P Gregoire (EP)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Emmanuelle Szenker-Ravi (E)

Institute of Medical Biology, A*STAR, Singapore, Singapore.

Marc Leushacke (M)

Institute of Medical Biology, A*STAR, Singapore, Singapore.

Bruno Reversade (B)

Institute of Medical Biology, A*STAR, Singapore, Singapore.

Marie-Christine Chaboissier (MC)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Andreas Schedl (A)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, Nice, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH